Microbiosci Launches High Quality Yeast Fermentation Services for Industry and cGMP Fermentation

January 28 18:21 2022
Microbiosci announced the release of its yeast fermentation services to accelerate its applications in industry and cGMP fermentation.

New York, USA – January 28, 2022 – Microbiosci, the division of Creative Biogene, is fully engaged in developing unique technologies and professional services in order to facilitate the development of microbial research. With years of experience and an expert team, Microbiosci is capable to provide a wide range of high-quality products and services in microbial genome editing, identification, sequencing, and metabolomics. Recently, Microbiosci announced the release of its yeast fermentation services to accelerate its applications in industry and cGMP fermentation.

Yeast is the expression system with the highest commercial value, and its fermentation technology is widely used in the production of chemical precursors, global food processing (such as coffee and chocolate), and even wastewater treatment. Microbiosci can use a variety of yeast types to produce bioethanol, and can undertake and optimize each of these major fermentation processes, including separate hydrolysis and fermentation (SHF), simultaneous saccharification and fermentation (SSF), and simultaneous saccharification and co-fermentation (SSCF).

Bioglycerol is gaining attention due to consumer demand for non-petroleum derived products and its potential as a feedstock for microbial chemical production. Microbiosci can design a process for the production of glycerol with high glucose concentrations using osmotolerant yeast. SCOs can be different produced edible oils and biofuels. Microbiosci provides technology to produce SCO from customers’ biomass and process liquids. In addition, emulsifiers are very important in the process of optimizing product quality and quantity. Microbiosci can guide customers through and optimize the emulsifier production process.

Microbiosci’s Saccharomyces cerevisiae fermentation platform has become the most studied and most utilized species for fermentation due to its good fermentation ability, rapid growth and easy adaptation. In addition, Microbiosci offers a Pichia fermentation platform to enhance the process of heterologous protein production.

Microbiosci’s yeast fermentation and expression services utilize proprietary yeast fermentation technology to produce high-yield, high-quality recombinant proteins in yeast by selecting stable and robust producing yeast strains that most closely resemble mammalian systems. Microbiosci is also equipped with a scaled-up yeast fermentation capacity of up to 10,000L. In addition, Creative Biogene also performs gene codon optimization for yeast strains such as Pichia pastoris and Saccharomyces cerevisiae to further increase recombinant product yield.

“We are capable to satisfy diverse requirements with abundant experience in biological fermentation, and multiple yeast cultures and expression vectors,” said Marcia Brady, the marketing director of Creative Biogene, she also added, “We can help you develop, characterize, manufacture, store, and distribute the microorganisms for applications in different fields.”

About Microbiosci

Microbiosci, as the division of Creative Biogene, is always dedicated to satisfying the needs of clients covering more than 50 countries and districts. As a leading custom service provider in delivering medicine microbiology solutions, Microbiosci has become a well-recognized industry leader with years of experience and professional scientists.

Media Contact
Company Name: Creative Biogene
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-386-8241
Country: United States
Website: https://microbiosci.creative-biogene.com